Ibrexafungerp Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 150 mg
Reference Brands: Brexafemme (USA)
Category: Anti-fungal
Ibrexafungerp is a novel oral antifungal medication that works by inhibiting (1,3)-β-D-glucan synthase, an enzyme vital for fungal cell wall synthesis. Marketed as Brexafemme in the USA, it offers the first new oral antifungal class in over 20 years. It is primarily used to treat and prevent vulvovaginal candidiasis (yeast infections) caused by Candida species. Ibrexafungerp is available in Tablets and strengths such as 150 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Ibrexafungerp is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Ibrexafungerp can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Ibrexafungerp is used to treat vulvovaginal candidiasis (VVC), a vaginal yeast infection, in adult and post‑menarchal adolescent females. It is also used to reduce the chance of recurrent vulvovaginal candidiasis (RVVC).
Ibrexafungerp is a triterpenoid antifungal compound that works by inhibiting β‑1,3‑D‑glucan synthase, an enzyme essential for fungal cell‑wall synthesis. This weakens the fungal cell wall and leads to fungal death.
The trade name of Ibrexafungerp is Brexafemme.
Ibrexafungerp (Brexafemme) is manufactured by SCYNEXIS, Inc.
The generic name is ibrexafungerp.
The brand name is Brexafemme.
Ibrexafungerp is manufactured by SCYNEXIS, Inc., and is available in certain markets as an oral tablet under the brand Brexafemme.
Related Products
Naftifine Hydrochloride
Strength:
1 %, 2%
Form: Cream / Gel
Reference Brands: Naftin (USA), Xolafin (USA)
View Details
Sertaconazole Nitrate
Strength:
2 %
Form: Creams
Reference Brands: Ertaczo (USA), Zalain (EU)
View DetailsQuick Response Guaranteed | Verified Suppliers
